CAR T-Cell Monitor delivers insights into the market dynamics in the CAR T-Cell therapy space, reflecting the collaboration practices between the CAR T sites and the referring physicians while providing a better understanding of the patient experience.

CAR T-Cell Monitor is available in France, Germany, Italy, Spain, the UK, Belgium, the US, Canada, Brazil and Japan.

Explore this fact sheet to see the benefits of linking CAR T-Cell center perspectives and referring physicians in one integrated offering or visit the Global Oncology Intelligence webpage for more details.